This work was supported by the following grants: NS032228 (D.B.C., S.E., Y.Y., D.S.), AI 069495 (D.B.C.), AI 69419, RR024996, and AI 51966 (R.M.G.). The project was also supported by award U01AI068636 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. Additional grants providing support include ACTG Central Group, AI38858, and the SDMC grant, AI68634.
The authors are grateful to the participants who volunteered to participate in this study. Participating sites and their grant support include: William E. Maher, MD, and Diane Gochnour, RN, Ohio State University (Site 2301), CTU Grant # AI069474; Linda Meixner, RN, and Susan Cahill, RN, UC San Diego Medical Center (Site 0701), CTU Grant # AI 69432; Jie Wang, RN, and Jeanne Schroder, Vanderbilt Therapeutics (Site 3652), CTU Grant # AI069439; David Currin, RN, and Susan Pedersen, RN, BSN, University of North Carolina (Site 3201), CTU Grant # 5-U01 AI069423-03, GCRC M01 RR000046-48, CFAR P30 AI050410(−11); Philip Keiser, MD, and Martha Malone, RN, UT Southwestern Medical Center at Dallas (Site 3751), CTU Grant # 3U01A1046376-05S4; Mitchell Goldman, MD, and Deborah O'Connor, RN, MSN, Indiana University (Site 2601), CTU Grant # AI25859; Jorge L. Santana Bagur, MD, and Santiago Marrero, MD, Puerto Rico-AIDS Clinical Trials Unit (Site 5401), CTU Grant # 5 U0I AI069415-03; Deborah McMahon, MD, and Barbara Rutecki, CRNP, MPH, Pittsburgh (Site 1001), CTU Grant # 1 UO1 AI 069494-01; Jim Scott and Steven Johnson, University of Colorado Health Sciences Center (Site 6101), CTU Grant # AI69450, NIH Grants RR025780 and AI54907; Roberto Corales, DO, and Christine Hurley, RN, AIDS Community Health Center (Site 1108), CTU Grant # U01 AI069511, GCRC Grant # UL1 RR 024160; Susan Swindells, MBBS, and Frances Van Meter, APRN, University of Nebraska Medical Center (Site 1505) CTU Grant # AI27661; Mark Rodriguez, RN, and Ge-Youl Kim, RN, Washington University at St. Louis (Site 2101), CTU Grant #5U01 AI069495; Donna McGregor and Baiba Berzins, Northwestern University CRS (Site 2701), CTU Grant # AI069471; Nathan M. Thielman, MD, and Martha Silberman, RN, Duke University Medical Center (Site 1601) CTU Grant # 5U01 AI069 484-02; Karen Tashima, MD, and Joan Gormley, RN, The Miriam Hospital Rhode Island (Site 2951), CTU Grant # A1069472; Tim Lane, MD, and Lisa Dasnoit, RN, Moses Cone Hospital (Site 3203), CTU Grant #1UO1 AI069423-01; Janet Forcht, RN, and Judith A. Aberg, MD, NY University HIV/AIDS CRS (Site 0401), CTU Grant # AI –27665, new Grant # AI069532, GCRC Grant # M01-RR00096; Donna Mildvan, MD, and Gwendolyn Costantini, FNP, Beth Israel Medical Center (Site 2851), CTU Grant # AI46370; Paul Sax, MD, and Lynn Dumas, RN, Brigham and Women's Hospital (Site 0107), CTU Grant # AI 069472; Jane Reid RN, MS, APN-BC, and Mary Adams, RN, MPH, University of Rochester (Site 1101), CTU Grant # U01 AI069511, GCRC Grant # UL1 RR 024160; James B. Thompson, RN, and Clifford J. Gunthel, MD, Emory University HIV/AIDS Clinical Trials Unit (Site 5802), CTU Grant # U01A169418-02; Todd Stroberg, RN, and Valery Hughes, RN, Cornell (Site 7804), CTU Grant # U01-AI69419, RR024996; Nayef El-Daher, MD, and Mary Adams, RN, MPH, McCree McCuller Wellness Center (Site 1107), CTU Grant # U01 AI069511, GCRC Grant # UL1 RR 024160; Jeffery L. Meier and Jack T. Stapleton, University of Iowa Hospitals (Site 1504), CTU Grant # AI 27661, AI 58740, CTSA NIH Grant # 5UL1RR024979; Harold A. Kessler, MD, and Margaret Travis, RN, Rush Presbysterian/St. Luke's (Site 2702), CTU Grant # U01 AI 069471; Mary Albrecht, MD, and Neah Kim, MSN, FNP, Beth Israel Deaconess (Site 0103), CTU Grant # U01 AI069472-03; Harvey Friedman, MD, and Wayne Wagner, RN, University of Pennsylvania (Site 6201), CTU Grant #ACTG U01-AI-069467-03, CFAR 5-P30-AI-045008-09.
Additional support includes Grant # AI 68636 (providing the Virology and Pharmacology Support Laboratories at Brigham and Women's Hospital, the University of Alabama, the University of Colorado Health Sciences Center, the University of North Carolina, and Vanderbilt University) from the National Institute of Allergy and Infectious Diseases, and the Neurologic AIDS Research Consortium Grant # NS 32228, National Institute of Neurological Disorders and Stroke, National Institute of Health supporting neurological training and testing. The clinical trial was further supported by donations of Boehringer Ingelheim, Bristol Myers Squibb, and GlaxoSmithKline. NCT number = NCT00013529.